Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

To assess the effect of fesoterodine 8 mg as compared to solifenacin 10 mg on colonic transit.

Key facts

Study ID

NCT00832650

Run by

Pfizer

People needed

60

Starts

2009-04-01

Expected to finish

2009-12-01

Last updated by the study team

2010-12-24

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Healthy female subjects

You may not qualify if…

• Evidence or history of clinically significant findings at screening

Where it is running

• Pfizer Investigational Site — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.